Leucocyte Depletion Of The Blood Supply – How Will Patients Benefit?
Lorna M. Williamson,
Lorna M. Williamson
University of Cambridge/National Blood Service, East Anglia Centre, Cambridge CB2 2PT, UK
Search for more papers by this authorLorna M. Williamson,
Lorna M. Williamson
University of Cambridge/National Blood Service, East Anglia Centre, Cambridge CB2 2PT, UK
Search for more papers by this author Lorna M. Williamson, Lecturer/Consultant in Transfusion Medicine, University of Cambridge/National Blood Service, East Anglia Centre, Cambridge CB2 2PT, UK. E-mail:
[email protected]
References
- Adams, M.R., Johnson, D.K., Busch, M.P., Schembri, C.T., Hartz, T.P., Heaton, W.A. (1997) Automatic volumetric capillary cytometry for counting white cells in white cell-reduced plateletpheresis components. Transfusion, 37, 29 37.
- Akahoshi, M., Takanashi, M., Masuda, M., Yamashita, H., Hidano, A., Hasegawa, K., Kasajima, T., Shimizu, M., Motoji, T., Oshimi, K., Mizoguchi, H. (1992) A case of transfusion associated graft versus host disease not prevented by white cell-reduction filters. Transfusion, 32, 169 172.
- Al, E.J.M., Visser, S.C.E., Broerson, S.M., Stienstra, S., Huisman, J.G. (1993) Reduction of HTLV-I-infected cells in blood by leukocyte filtration. Annals of Hematology, 67, 295 300.
- Alcorta, I., Pereira, A., Ordinas, A. (1996) Clinical and laboratory factors associated with platelet transfusion refractoriness: a case–control study. British Journal of Haematology, 93, 220 224.
- Amato, A.C. & Pescatori, M. (1998) Effect of perioperative transfusions on recurrence of colorectal cancer. Diseases of the Colon and Rectum, 41, 570 585.
- Anderson, N.A., Gray, S., Copplestone, J.A., Chan, D.C., Hamon, M., Prentice, A.G., Johnson, S.A.N., Phillips, M., Van Waeg, G., Oakhill, A., Abeyasekera, S., Pamphilon, D.H. (1997) A prospective randomised study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions. Transfusion Medicine, 6, 33 39.
- Anderson, R.M., Donnelly, C.A., Ferguson, N.M., Woolhouse, M.E., Watt, C.J., Udy, H.J., Mawhinney, S., Dunstan, S.P., Southwood, T.R., Wilesmith, J.W., Ryan, J.B., Hoinville, L.J., Hillerton, J.E., Austin, A.R., Wells, G.A. (1996) Transmission dynamics and epidemiology of BSE in British cattle. Nature, 382, 779 788.
- Andreu, G., Dewailly, J., Leberre, C., Quarre M.C., Bidet, M.L., Tardivel, R, Devers, L., Lam, Y., Soreau, E., Boccaccio, C., Piard, N., Bidet, J.M., Genetet, B., Fauchet, R. (1988) Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood, 72, 964 969.
- Aye, M.T., Palmer, D.S., Giulivi, A. (1995) Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion, 35, 117 124.
- Barclay, G.R., Hope, J., Birkett, C.R., Turner, M.L. (1999) Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry. British Journal of Haematology, 107, 804 814.
- Barnett, D., Granger, V., Storie, I., Peel, J., Pollitt, R., Smart, T., Reilly, J.T. (1998) Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. British Journal of Haematology, 102, 553 565.
- Bishop, J.F., McGrath, K., Wolf, M.M., De Matthews, J.P., Luise, T., Holdsworth, R., Yuen, K., Veale, M., Whiteside, M.G., Cooper, I.A., Szer, J. (1988) Clinical factors influencing the efficacy of pooled platelet transfusions. Blood, 71, 383 387.
- Blackbourn, D.J., Ambroziak, J., Lennette, E., Adams, M., Ramachandran, B., Levy, J.A. (1997) Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet, 349, 609 611.DOI: 10.1016/s0140-6736(96)10004-0
- Blajchman, M.A. (1999) Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion, 39, 665 670.
- Blajchman, M.A., Bardossy, L., Carmen, R., Sastry, A., Singal, D.P. (1993) Allogeneic blood transfusion-induced enhancement of tumour growth in two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood, 81, 1880 1882.
- Blajchman, M.A., Ali, A.M., Richardson, H.L. (1994) Bacterial contamination of cellular blood components. Vox Sanguinis, 67, 25 34.
- Blumberg, N. & Heal, J.M. (1996) Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. American Journal of Medicine, 101, 299 308.
- Bock, M., Muggenthaler, K.-H., Schmidt, U., Heim, M.U. (1996) Influence of antibiotics on posttransfusion platelet increment. Transfusion, 36, 952 954.
- Bodensteiner, D. (1994) White cell reduction in blood from donors with sickle cell trait. Transfusion, 34, 84.
- Bordin, J.O., Heddle, N.M., Blajchman, M.A. (1994a) Biologic effects of leukocytes present in transfused cellular blood products. Blood, 84, 1703 1721.
- Bordin, J.O., Bardossy, L., Blajchman, M.A. (1994b) Growth enhancement of established tumours by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion; the importance of the timing of the leukodepletion. Blood, 84, 344 348.
- Bordin, J.O., Chiba, A.K., Carvalho, K.I.L., Takata, E.T., Falcão, O.R.P., Garcia, A.B., Bordin, I.A.S., Maciel, M.M., Andreoni, S., Kerbauy, J. (1999) The effect of unmodified or prestorage white cell-reduced allogeneic red cell transfusions on the immune responsiveness of orthopedic surgery patients. Transfusion, 39, 718 723.
- Bowden, R.A., Sayers, M.H., Cays, M., Slichter, S.J. (1989) The role of blood product filtration in the prevention of transfusion associated cytomegalovirus (CMV) infection after marrow transplant. Transfusion, 29, 57S.
- Bowden, R.A., Slichter, S.J., Sayers, M.H., Mori, M., Cays, M.J., Meyers, J.D. (1991) Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood, 78, 246 250.
- Bowden, R.A., Slichter, S.J., Sayers, M., Weisdorf, D., Cays, M., Schoch, G., Banaji, M., Haake, R., Welk, K., Fisher, L., McCullough, J., Miller, W. (1995) A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood, 86, 3598 3603.
- Brown, P., Gibbs, C.J., Rodgers-Johnson, P., Asher, D.M., Sulima, M.P., Bacote, A., Goldfarb, L.G., Gajdusek, D.C. (1994) Human spongiform encephalopathy: The National Institutes of Health series of 300 experimentally transmitted cases. Annals of Neurology, 35, 513 529.
- Brown, P., Rohwer, R.G., Dunstan, B.C., MacAuley, C., Gajdusek, D.C., Drohan, W.N. (1998) The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion, 38, 810 816.
- Bruce, M.E., Will, R.G., Ironside, J.W., McConnell, I., Drummond, D., Suttle, A., McCardle, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H., Bostock, C.J. (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature, 389, 498 501.
- Buchanan, C.R., Preece, M.A., Milner, R.D.G. (1991) Mortality, neoplasia, and Creutzfeldt–Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. British Medical Journal, 302, 824 828.
- Bucholtz, D.H., AuBuchon, J.P., Snyder, E.L., Kandler, V., Piscitelli, V., Pickard, C., Napychank, P., Edberg, S. (1994) Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion, 34, 852 857.
- Busch, O.R., Hop, W.C.J., Hoynck van Papendrecht, M.A., Marquet, R.L., Jeekel, J. (1993) Blood transfusions and prognosis in colorectal cancer. New England Journal of Medicine, 328, 1372 1376.
- Canavaggio, M., Leckie, G., Allain, J.-P., Steaffens, J.W., Laurian, Y., Brettler, D., Lee, H. (1990) The prevalence of antibody to HTLV-I/II in United States plasma donors and in United States and French hemophiliacs. Transfusion, 30, 780 782.
- Cardigan, R., Krailadsiri, P., Seghatchian, M.J., Beckman, N., Williamson, L.M. (1999a) Quality of leucodepleted plasma produced by whole blood filtration. Transfusion Medicine, 9, 47.
- Cardigan, R., Sutherland, J., Garwood, M., Swann, K., Stenning, M., Seghatchian, M.J., Williamson, L.M. (1999b) Evaluation of a novel filter for leucocyte depletion of fresh plasma. Transfusion Medicine, 9, 46.
- Carson, J.L., Altman, D.G., Duff, A., Noveck, H., Weinstein, M.P., Sonnenberg, F.A., Hudson, J.I., Provenzano, G. (1999) Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion, 39, 694 700.
- Chiu, E.K.W., Yuen, K.Y., Lie, A.K.W., Liang, R., Lau, Y.L., Lee, A.C.W., Kwong, Y.L., Wong, S., Ng, M.H., Chan, T.K. (1994) A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion, 34, 950 954.
- Claas, F.H.J., Smeenk, R.J.T., Schmidt, R., Van Steenbrugge, G.J., Ernisse, J.G. (1981) Alloimmunisation against the MHC antigens after platelet transfusions is due to contaminating leucocytes in the platelet suspension. Experimental Hematology, 9, 84 89.
- Communicable Disease Control (1997) Initiation of a national study to detect bacteria-associated transfusion reactions. Morbidity and Mortality Weekly Report, 46, 554 555.
- Copplestone, J.A., Williamson, P., Norfolk, D.R., Morgenstern, G.R., Wimperis, J.Z., Williamson, L.M. (1995) Wider benefits of leukodepletion of blood products. Blood, 86, 409 410.
- Council of Europe (1999) Guide to the Preparation, Use and Quality Assurance of Blood Components, 5th edn. Council of Europe Publishing, Strasbourg.
- Cousens, S.N., Vynnycky, E., Zeidler, M., Will, R.G., Smith, P.G. (1997) Predicting the CJD epidemic in humans. Nature, 385, 197 198.
- De Graan-hentzen, Y.C., Gratama, J.W., Mudde, G.C., Verdonck, L.F., Houbiers, J.G., Brand, A., Sebens, F.W., Van Loon, A.M., The, T.H., Willemze, R. (1989) Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion, 29, 757 760.
- Department of Health (1998) Government accepts advice on leucodepletion from Spongiform Encephalopathy Advisory Committee. Press release 98/295, 17 July.
- Det Norske Veritas Report (1999) Assessment of the Risk of Exposure to vCJD Infectivity in Blood and Blood Products for the Spongiform Encephalopathy Advisory Committee and the (UK) Department of Health. Det Norske Veritas .
-
De Witte, T.,
Schattenberg, A.,
Van Dijk, B.A.,
Galama, J.,
Olthuis, H.,
Van Der Meer, J.W.,
Kunst, V.A. (1990) Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
Transplantation, 59, 964 968.
10.1097/00007890-199012000-00013 Google Scholar
- Dodd, R.R.Y. (1994) Impact of leukodepletion on infections other than cytomegalovirus. In: Leukocyte-Depleted Blood Products (ed. by T.A. Lane & G. Myllylä). Karger, Basel.
- Dodelet, V.C. & Cashman, N.R. (1998) Prion protein expression in human leukocyte differentiation. Blood, 91, 1556 1561.
- Donegan, E., Lee, H., Operskalski, E.A., Shaw, G.M., Kleinman, S.H., Busch, M.P., Stevens, C.E., Schiff, E.R., Nowicki, M.J., Hollingsworth, C.G., Mosley, J.W. & the Transfusion Safety Study Group (1994) Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion, 34, 478 483.
- Doughty, H.A., Murphy, M.F., Metcalfe, P., Rohatiner, A.Z.S., Lister, T.A., Waters, A.H. (1994) Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sanguinis, 66, 200 205.
- Dumont, L.J., Dzik, W.H., Rebulla, P., Brandwein, H. & the members of the BEST Working Party of the ISBT (1996) Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT). Transfusion, 36, 11 20.
- Dzieczkowski, J.S., Barrett, B.B., Nester, D., Campbell, M., Cook, J., Sugrue, M., Andersen, J.W., Anderson, K.C. (1995) Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion, 35, 20 25.
- Dzik, W.H. (1994) Mononuclear cell microchimerism and the immunomodulatory effect of transfusion. Transfusion, 34, 1007 1012.
- Dzik, S., Blajchman, M.A., Blumberg, N., Kirkley, S.A., Heal, J.M., Wood, K. (1996) Current research on the immunomodulatory effect of allogeneic blood transfusion. Vox Sanguinis, 70, 187 194.
- Editorial (1988) Lancet, i, 565 568.
- Eernisse, J.G. & Brand, A. (1981) Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Experimental Hematology, 9, 77 83.
- Eisenfeld, L., Silver, H., McLaughlin, J., Klevjer-Anderson, P., Mayo, D., Anderson, J., Herson, V., Krause, P., Savidakis, J., Lazar, A., Rosenkrantz, T., Pisciotto, P. (1992) Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion, 32, 205 209.
- Fernandez, M.C., Gottlieb, M., Menitove, J.E. (1992) Blood transfusion and post operative infection in orthopedic patients. Transfusion, 32, 318 322.
- Finkel, E. (1996) Keeping an open mind about prions. Lancet, 348, 326.
- Fisher, M., Chapman, J.R., Ting, A., Morris, P.J. (1985) Alloimmunisation to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions. Vox Sanguinis, 49, 331 335.
- Food and Drug Administration, Blood Products Advisory Committee 60th Meeting (1998) Routine Leukoreduction of Blood Components. Food and Drug Administration, Rockville, MD.
-
Gilbert, G.L.,
Hayes, K.,
Hudson, I.L.,
James, J. (1989) Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.
Lancet, i, 1228 1231.
10.1016/S0140-6736(89)92330-1 Google Scholar
- Gluckman, E., Parquet, N., Scieux, C., Deplanche, M., Traineau, R., Betheau, P., Morinet, F. (1995) KS-associated herpesvirus-like DNA sequences after allogeneic bone-marrow transplantation. Lancet, 346, 1558 1559.
- Goodnough, L.T., Riddell, J., Lazarus, H., Chafel T.L., Prince, G., Hendrix, D., Yomtovian, R. (1993) Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration. Vox Sanguinis, 65, 103 107.
- Heaton, W.A., Rebulla, P., Pappalettera, M., Dzik, W.H. (1997) A comparative analysis of different methods for routine blood component preparation. Transfusion Medicine Review, 11, 116 129.
- Heddle, N.M. & Blajchman, M.A. (1995) The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions. Blood, 85, 603 606.
- Heddle, N.M., Luba Klama, R.T., Singer, J., Richards, C., Fedak, P., Walker, I., Kelton, J.G. (1994) The role of the plasma from platelet concentrates in transfusion reactions. New England Journal of Medicine, 331, 625 628.
- Heiss, M.M., Mempel, W., Jauch, K.W., Delanoff, C., Mayer, G., Mempel, M., Eissner, H.-J., Schildberg, F.-H. (1993) Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet, 342, 1328 1333.
- Heiss, M.M., Mempel, W., Delanoff, C., Jauch, K.W., Gabka, C., Mempel, M., Dieterich, H.-J., Eissner, H.-J., Schildberg, F.-W. (1994) Blood transfusion – modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. Journal of Clinical Oncology, 12, 1859 1867.
- Hill, A.F., Desbruslais, M., Joiner, S., Sidle, K.C.L., Gowland, I., Collinge, J. (1997) The same prion strain causes vCJD and BSE. Nature, 389, 448 450.
- Hill, A.F., Butterworth, R.J., Joiner, S., Jackson, G., Rossor, M.N., Thomas, D.J., Frosh, A., Tolley, N., Bell, J.E., Spencer, M., King, A., Al-Sarraj, S., Ironside, J.W., Lantos, P.L., Collinge, J. (1999) Investigation of variant Creutzfeldt–Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet, 353, 183 189.DOI: 10.1016/s0140-6736(98)12075-5
- Hillyer, C.D., Emmens, R.K., Zago-Novaretti, M., Berkman, E.M. (1994) Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion, 34, 929 934.
- Hillyer, C.D., Lankford, K.V., Roback, J.D., Gillespie, T.W., Silberstein, L.E. (1999) Transfusion of the HIV-seropositive patient; immunomodulation, viral reactivation and limiting exposure to EBV (HHV-4), CMV (HHV-5) and HHV-6, 7 and 8. Transfusion Medicine Reviews, 13, 1 17.
- Hilton, D.A., Fathers, E., Edwards, P., Ironside, J.W., Zajicek, J. (1998) Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt–Jakob disease. Lancet, 352, 703 704.DOI: 10.1016/s0140-6736(98)24035-9
- Houbiers, J.G., Brand, A., Van De Watering, L.M., Hermans, J., Verwey, P.J.M., Bijnen, A.B., Pahlplatz, P., Schattenkerk, M.E., Wobbes, T., De Vries, J.E., Klementschitsch, P., Van De Maas, A.H.M., Van De Velde, C.J.H. (1994) Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet, 344, 573 578.
- Houbiers, J.G., Van De Velde, C.J., Van De Watering, L.M., Hermans, J., Schreuder, S., Bijnen, A.B., Pahlplatz, P., Eeftinck Schattenkerk, M., Wobbes, T., De Vries, J.E., Klementschitsch, P., Van De Maas, A.H., Brand, A. (1997) Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion, 37, 126 134.
- Hume, H.A., Popovsky, M.A., Benson, K., Glassman, A.B., Hines, D., Oberman, H.A., Pisciotto, P.T., Anderson, K.C. (1996) Hypotensive reactions: a previously uncharacterized complication of platelet transfusion? Transfusion, 36, 904 909.
- James, D.J., Sikotra, S., Sivakumaran, M., Wood, J.K., Revill, J.A., Bullen, V., Myint, S. (1997) The presence of free infectious cytomegalovirus (CMV) in the plasma of donated CMV-seropositive blood and platelets. Transfusion Medicine, 7, 123 126.
- Jensen, L.S., Andersen, A.J., Christiansen, P.M., Hokland, P., Juhl, C.O., Madsen, G., Mortensen, J., Møller-Nielsen, C., Hanberg-Sorensen, F.J., Hokland, M. (1992) Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. British Journal of Surgery, 79, 513 516.
- Jensen, L.S., Kissmeyer-Nielsen, P., Wolff, B., Qvist, N. (1996) Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet, 348, 841 845.DOI: 10.1016/s0140-6736(96)06168-5
- Kataoka, R., Takehara, N., Iwahara, Y., Sawada, T., Ohtsuki, Y., Dawei, Y., Hoshino, H., Miyoshi, I. (1990) Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood, 76, 1657 1661.
- Keown, P.A. (1987) The highly sensitized patient: etiology, impact and management. Transplantation Proceedings, XIX, 74 78.
- Killick, S.B., Win, N., Marsh, J.C.W., Kaye, T., Yandle, A., Humphries, C., Knowles, S.M., Gordon-Smith, E.C. (1997) Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia. British Journal of Haematology, 97, 677 684.
- Klein, M.A., Frigg, R., Flechsig, E., Raeber, A.J., Kalinke, U., Bluethmann, H., Bootz, F., Suter, M., Zinkernagel, R.M., Aguzzi, A. (1997) A crucial role for B cells in neuroinvasive scrapie. Nature, 390, 687 690.
- Klein, M.A., Frigg, R., Raeber, A.J., Flechsig, E., Hegyi, I., Zinkernagel, R.M., Weissmann, C., Aguzzi, A. (1998) PrP expression in B-lymphocytes is not required for prion neuroinvasion. Nature Medicine, 4, 1429 1433.
- Kleinman, S., Swanson, P., Allain, J.-P., Lee, H. (1993) Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion, 33, 14 18.
- Krailadsiri, P., Seghatchian, J., Bode, A.P. (1997) Microvesicles in blood components: laboratory and clinical aspects. Clinical Applied Thrombosis/ Haemostasis, 3, 86 95.
- Kurz, M., Greinix, H., Hocker, P., Kalhs, P., Knöbl, P., Mayr, W.R., Pober, M., Panzer, S. (1996) Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders. British Journal of Haematology, 95, 564 569.
- Lagaaij, E.L., Hennemann, P.H., Ruigrok, M., De Haan, M.W., Persijn, G.G., Termijtelen, A., Hendriks, G.F.J., Weimar, W., Claas, F.H.J., Van Rood, J.J. (1989) Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. New England Journal of Medicine, 321, 701 705.
- Larsson, S., Söderberg-Nauclér, C., Möller, E. (1998a) Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals. implications for prevention of CMV transmission. Transplantation, 65, 411 415.
- Larsson, S., Söderberg-Nauclér, C., Wang, F.-Z., Möller, E. (1998b) Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion, 38, 271 278.
- Lee, H.H., Swanson, P., Shorty, V.S., Zack, J.A., Rosenblatt, J.D., Chen, I.S.Y. (1989) High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science, 244, 471 475.
- Lee, H.H., Galli, C., Burczak, J.D., Biffoni, F., De Stasio, G., De Virgiliis, S., Fanetti, G., Lai, M.E., Mannella, E., Marinucci, G., Ongaro, G., Zehender, G. & members of the Italian HTLV Collaborative Study Group. (1994) A multicentric seroepidemiological survey of HTLV-I/II in Italy. Clinical and Diagnostic Virology, 2, 139 148.
- Lefrere, J.-J., Mariotti, M., Girot, R., Loiseau, P., Herve, P. (1997) Transfusional risk of HHV-8 infection. Lancet, 350, 217.
- McAlister, F.A., Clark, H.D., Wells, P.S., Laupacis, A. (1998) Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. British Journal of Surgery, 85, 171 178.
- McCann, S.R., Bacigalupo, A., Gluckman, E., Hinterberger, W., Hows, J., Ljungman, P., Marin, P., Nissen, C., Van't Veer Kerthof, E., Raghavachar, A., Socie, G., Frickhofen, N., Locasciulli, A., Schrezenmeier, H. (1994) Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplantation, 13, 233 237.
- MacGregor, I., Hope, J., Barnard, G., Kirby, L., Drummond, O., Pepper, D., Hornsey, V., Barclay, R., Bessos, H., Turner, M.L., Prowse, C. (1999) The distribution of normal prion protein in human blood. Vox Sanguinis, 77, 88 96.
- Mangano, M.M., Chambers, L.A., Kruskall, M.S. (1991) Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. American Journal of Clinical Pathology, 95, 733 738.
- Manns, A., Wilks, R.J., Murph, E.L., Haynes, G., Figueroa, J.P., Barnet, M., Hanchard, B., Blattner, W.A. (1992) A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. International Journal of Cancer, 51, 886 891.
- Manuelidis, E.E., Kim, J.H., Mericangas, J.R., Manuelidis, L. (1985) Transmission to animals of Creutzfeldt–Jakob disease from human blood. Lancet, 2, 896 897.
- Mendelson, M., Monard, S., Sissons, P., Sinclair, J. (1996) Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. Journal of General Virology, 77, 3099 3102.
- Metcalfe, P., Williamson, L.M., Reutelingsperger, C.P.M., Swann, I., Ouwehand, W.H., Goodall, A.H. (1997) Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. British Journal of Haematology, 98, 86 95.
- Mezrow, C.K., Bergstein, I., Tartter, P.I. (1992) Post operative infections following autologous and homologous blood transfusions. Transfusion, 32, 212 217.
- Morrow, J.F., Braine, J.G., Kickler, T.S., Ness P.M., Dick, J.D., Fuller, A.K. (1991) Septic reactions to platelet transfusions. Journal of the American Medical Association, 266, 555 558.
- Murphy, M.F., Grint, P.C., Hardiman, A.E., Lister, T.A., Waters, A.H. (1988) Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia. British Journal of Haematology, 70, 253 254.
- Murphy, M.F., Kinsey, S., Murphy, W., Pamphilon, D., Warwick, R., Williamson, L.M., Wood, J.K. for the British Committee for Standards in Haematology, Blood Transfusion Task Force. (1998a) Guidelines on the clinical use of leucocyte-depleted blood components. Transfusion Medicine, 8, 59 71.
- Murphy, M.F., Stevens, W., Green, E.S., Allison, P., Smith, D. (1998b) Universal leucocyte depletion of blood components – con. Infusiontherapie und Transfusionsmedizin [Infusion Therapy and Transfusion Medicine], 25, 305 311.
- Murphy, P., Heal, J.M., Blumberg, N. (1991) Infection or suspected infection after hip replacement with autologous or homologous blood transfusion. Transfusion, 31, 212 217.
- Muylle, L. & Peetermans, M.E. (1994) Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sanguinis, 66, 14 17.
- Muylle, L., Wouters, E., De Bock, R., Peetermans, M.E. (1992) Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transfusion Medicine, 2, 289 293.
- Muylle, L., Joos, M., Wouters, E., De Bock, R., Peetermans, M.E. (1993) Increased tumor necrosis factor α (TNFα) interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates. relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion, 33, 195 199.
- Norol, F., Kuentz, M., Cordonnier, C., Beaujean, F., Haioun, C., Vernant, J.P., Duédari, N. (1994) Influence of clinical status on the efficiency of stored platelet transfusion. British Journal of Haematology, 86, 125 129.
- Novotny, V.M.J., Van Doorn, R., Witvliet, M.D., Claas, F.H.J., Brand, A. (1995) Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood, 85, 1736 1741.
- Okochi, K., Sato, H., Hinuma, Y. (1984) A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sanguinis, 46, 245 253.
- Oksanen, K., Kekomäki, R., Ruutu, T., Koskimies, S., Myllalä, G. (1991) Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components – a randomized trial. Transfusion, 31, 588 594.
- Oksanen, K. & Elonen, E. for the Finnish Leukaemia Group (1993) Impact of leucocyte-depleted blood components on the haematological recovery and prognosis of patients with acute myeloid leukaemia. British Journal of Haematology, 84, 639.
- Olsen, K.E. & Sandler, S.G. (1996) Febrile neutropenia contributes to underreporting of potential septic platelet transfusion reactions. Vox Sanguinis, 70, 118.
- Opelz, G., Mickey, M.R., Sengar, D.P.S., Terasaki, P. (1973) Effect of blood transfusions on subsequent kidney transplants. Transplant Proceedings, 5, 253.
- Opelz, G., Vanrenterghem, Y., Kirste, G., Gray, D.W.R., Horsburgh, T., Lachance, J.-G., Largiader, F., Lange, H., Vujaklija-Stipanovic, K., Alvarez-Grande, J., Schott, W., Hoyer, J., Schnuelle, P., Descoeudres, C., Ruder, H., Wujciak, T., Schwarz, V. (1997) Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation, 63, 964 967.
- Pamphilon, D.H., Rider, J.R., Barbara, J.A.J., Williamson, L.M. (1999a) Prevention of transfusion-transmitted cytomegalovirus infection. Transfusion Medicine, 9, 115 123.
- Pamphilon, D.H., Foot, A.B.M., Adeodu, A., Steward, C.G., Cornish, J.M., Marks, D.I., Oakhill, A. (1999b) Prophylaxis and prevention of CMV infection in BM allograft recipients. Leucodepleted platelets are equivalent to those from CMV seronegative donors (Abstract, 25th Annual Meeting EBMT), Bone Marrow Transplantation, 23, S66.
- Parravicini, C., Olsen, S.J., Capra, M., Poli, F., Sirchia, G., Gao, S.-J., Berti, E., Nocera, A., Rossi, E., Bestetti, G., Pizzuto, M., Galli, M., Moroni, M., Moore, P., Corbellino, M. (1997) Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood, 90, 2826 2829.
- Pennington, J. & Williamson, L.M. (1999) Analysis of leucocyte subset specific expression markers using Taqman real-time quantitative PCR. Transfusion Medicine, 9, 20.
- Perini, F., Vidal, R., Ghetti, B., Tagliavini, F., Frangione, B., Prelli, F. (1996a) PrP27−30 is a normal soluble prion protein fragment released by human platelets. Biochemical and Biophysical Research Communications, 23, 572 577.
- Perini, F., Frangione, B., Prelli, F. (1996b) Prion protein released by platelets. Lancet, 347, 1635 1636.
- Popovsky, M.A., Chaplin, Jr, H.C., Moore, S.B. (1992) Transfusion-related acute lung injury: a neglected serious complication of haemotherapy. Transfusion, 32, 589 592.
- Prowse, C.V., Hornsey, V.S., Drummond, O., MacGregor, I.R., Pepper, D.S., Barclay, G.R., Bethel, H., Walker, B., Barnard, G., Kirby, L., Hope, J. (1999) Preliminary assessment of whole-blood, red-cell and platelet-leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing. British Journal of Haematology, 106, 240 247.
- Richardson, J.H., Edwards, A.J., Cruickshank, J.K., Rudge, P., Dalgleish, A.G. (1990) In vivo cellular tropism of human T-cell leukemia virus type 1. Journal of Virology, 64, 5682 5687.
- Saarinen, U.M., Kekomäki, R., Siimes, M.A., Myllylä, G. (1990) Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood, 75, 512 517.
- Semple, J.W., Speck, E.R., Cosgrave, D., Lazarus, A.H., Blanchette, V.S., Freedman, J. (1999) Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity. Blood, 93, 713 720.
- Shiba, M., Tadokoro, K., Sawanobori, M., Nakajima, K., Suzuki, K., Juji, T. (1997) Activation of the contract system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received the filtered platelets. Transfusion, 37, 457 462.
- Silliman, C.C. (1999) Transfusion-related acute lung injury. Transfusion Medicine Reviews, 13, 177 186.
- Sinclair, J. & Sissons, P. (1996) Latent and persistent infections of monocytes and macrophages. Intervirology, 39, 293 301.
- Sintnicolaas, K., Van Marwijk Kooij, M., Van Prooijen, H.C., Van Dijk, B.A., Van Putten, W.L.J., Claas, F.H.J., Novotny, V.M.J., Brand, A. (1995) Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunisation and refractoriness: a randomized prospective study. Blood, 85, 824 828.
- Smith, K.L., Cobain, T., Dunstan, R.A. (1993) Removal of cytomegalovirus DNA from donor blood by filtration. British Journal of Haematology, 83, 640 642.
- Sniecinski, I., O'donnell, M.R., Nowicki, B., Hill, L.R. (1988) Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood, 71, 1402 1407.
- Söderberg-Nauclér, C., Fish, K.N., Nelson, J.A. (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell, 91, 119 126.
- Sowemimo-Coker, S.O., Kim, A., Tribble, E., Brandwein, H.J., Wenz, B. (1998) White cell subsets in apheresis and filtered platelet concentrates. Transfusion, 38, 650 657.
- Stack, G., Baril, L., Napychank, P., Snyder, E.L. (1995) Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion, 35, 199 203.
- Stationery Office (2000) Guidelines for the United Kingdom Transfusion Services, 4th edn. Stationery Office ( in press).
- Sullivan, M.T., Williams, A.E., Fang, C.T., Grandinetti, T., Poiesz, B.J., Ehrlich, G.D. for the American Red Cross HTLV-IIII. Collaboratory Study Group (1991) Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). Archives of Internal Medicine, 151, 2043 2048.
- Sweeney, J.D., Holme, S., Stromberg, R.R., Heaton, W.A.L. (1995) In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion, 35, 125 130.
- Tartter, P.I., Mohandas, K., Azar, P., Endres, J., Kaplan, J., Spivack, M. (1998) Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery, 176, 462 466.
- Tateishi, J. (1985) Transmission of Creutzfeldt–Jakob disease from human blood and urine into mice. Lancet, 2, 896 897.
- Trial to Reduce Alloimmunisation to Platelets (TRAP) Study Group. (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New England Journal of Medicine, 337, 1861 1869.
- Triulzi, D.J., Vanek, K., Ryan, D.H., Blumberg, N. (1992) A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion, 32, 517 524.
- Tucker, J., Murphy, M.F., Gregory, W.M., Lim, J., Rohatiner, A.Z.S., Waters, A.H., Lister, T.A. (1989) Apparent removal of graft-versus-leukaemia effect by the use of leucocyte-poor blood components in patients with acute myeloblastic leukaemia. British Journal of Haematology, 73, 572.
- Turner, M.L. (1999) The impact of new variant Creutzfeldt–Jakob disease on blood transfusion practice. British Journal of Haematology, 106, 842 850.
- Turner, M.L. & Ironside, J.W. (1998) New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. Blood Reviews, 12, 255 268.
- Vamvakas, E.C. (1995) Perioperative blood transfusion and cancer recurrence. meta-analysis for explanation. Transfusion, 35, 760 768.
- Vamvakas, E.C. (1996) Transfusion-associated cancer recurrence and postoperative infection. meta-analysis of randomized controlled clinical trials. Transfusion, 36, 175 186.
- Vamvakas, E.C. & Carven, J.H. (1998) Allogeneic blood transfusion, hospital charges, and length of hospitalization. A study of 487 consecutive patients undergoing colorectal cancer resection. Archives of Pathological Laboratory Medicine, 122, 145 151.
- Van De Watering, L.M.G., Hermans, J., Houbiers, J.G.A., Van Den Broek, P.J., Bouter, H., Boer, F., Harvey, M.S., Huysmans, H.A., Brand, A. (1998) Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery. a randomized clinical trial. Circulation, 97, 562 568.
- Van Marwijk Kooy, M., Hendrik, C., Van Prooijen, H.C., Moes, M., Bosma-Stants, I., Akkerman, J.-W.N. (1991) Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective randomized trial. Blood, 77, 201 205.
- Van Prooijen, H.C., Visser, J.J., Van Oostendorp, W., De Gast, G.C., Verdonck, L.F. (1994) Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. British Journal of Haematology, 87, 144 147.
- Van Prooijen, H.C., Aarts-Riemens, M.I., Van Oostendorp, W.R., Hene, R.J., Gmelig-Meyling, F.H.J., De Weger, R.A. (1995) Prevention of donor-specific T-cell unresponsiveness after buffy-coat-depleted blood transfusion. British Journal of Haematology, 91, 219 223.
- Van Twuyver, E., Mooijaart, R.J.D., Ten Berge, I.J.M, ., van der Horst, A.R., Wilmink, J.M., Kast, W.M., Melief, C.J.M, . & de Waal L.P. (1991) Pretransplantation blood transfusion revisited. New England Journal of Medicine, 325, 1210 1213.
- Verdonck, L.F., De Graan-Hentzen, Y.C., Dekker, A.W., Mudde, G.C., De Gast, G.C (1987) Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation. Bone Marrow Transplantation, 2, 73 78.
- Vervoordeldonk, S.F., Doumaid, K., Remmerswaal, E.B.M., Ten Berge, I.J.M., Wilmink, J.M., De Waal, L.P., Boog, C.J.P. (1998) Long-term detection of microchimaerism in peripheral blood after pre-transplantation blood transfusion. British Journal of Haematology, 102, 1004 1009.
- Will, R.G., Ironside, J.W., Zeidler, M., Cousens, S.N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A., Smith, . P.G. (1996) A new variant of Creutzfeldt–Jakob disease in the UK. Lancet, 347, 921 925.
- Williamson, L.M. (1999) New variant Creutzfeld–Jacob disease and leucocyte depletion of blood components. Infusionstherapie and Transfusionsmedizin [Infusion Therapy and Transfusion Medicine], 26 (Suppl. 2) 24–30 .
- Williamson, L.M. & Warwick, R.M. (1995) Transfusion-associated graft-versus-host disease and its prevention. Blood Reviews, 9, 251 261.
- Williamson, L.M., Wimperis, J.Z., Williamson, P., Copplestone, J.A., Gooi, H.C., Morgernstern, G.R., Norfolk, D.R. (1994) Bedside filtration of blood products in the prevention of HLA alloimmunisation – a prospective randomised study. Blood, 83, 3028 3035.
- Williamson, L.M., Baglin, T., Copplestone, A., Dendy, P., Forman, K., Gibson, B., Knowles, S., Morgan, G., Norfolk, D., Richards, A., Todd, A., Warwick, R., Webb, D. for BCSH Transfusion Task Force (1996) Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfusion Medicine, 6, 261 271.
- Williamson, L.M., Beard, M., Seghatchian, M.J., Cardigan, R., Booker, W., Heslip, J., Bennett, J., Smith, K., Boralessa, H. (1999a) Leukocyte depletion of whole blood and red cells from donors with hemoglobin sickle trait. Transfusion, 39 (suppl. 10), p. 108.
- Williamson, L.M., Lowe, S., Love, E., Cohen, H., Soldan, K., McClelland, D.B.M., Norfolk, D.R., Revill, J., Barbara, J.A.J., Birrell, D., Todd, A. (1999b) Serious Hazards of Transfusion Annual Report 1997–98, pp. 50 54. SHOT Office, Manchester.
- Williamson, L.M., Lowe, S., Love, E.M., Cohen, H., McClelland, D.B.L., Skacel, P., Barbara, J.A.J. (1999c) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. British Medical Journal, 319, 16 19.
- Yomtovian, R., Lazarus, H.M., Goodnough, L.T., Hirschler, N.V., Morrissey, A.M., Jacobs, M.R. (1993) A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion, 33, 902 909.
- Zeidler, M., Stewart, G., Cousens, S.N., Estibeiro, K., Will, R.G. (1997) Codon 129 genotype and new variant Creutzfeld–Jakob disease. Lancet, 350, 668.
- Zhuravskaya, T., Maciejewski, J.P., Netski, D.M., Bruening, E., Mackintosh, F.R., St Jeor, S. (1997) Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells. Model of HCMV latency. Blood, 90, 2482 2491.
Citing Literature
